Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports Second Quarter 2013 Financial Results
7/25/2013 9:33:00 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass., July 25, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business highlights for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.